Literature DB >> 8286090

Acinetobacter in Denmark: I. Taxonomy, antibiotic susceptibility, and pathogenicity of 112 clinical strains.

P Gerner-Smidt1, W Frederiksen.   

Abstract

One hundred and twelve clinical strains of Acinetobacter were collected during a 7-month period in 1990-1991 from Danish clinical microbiology departments. According to the old notation, 37 strains were biovar anitratus and 75 b.lwoffii. Using the newest terminology, 35 strains were unambiguously identified as the species A. haemolyticus, A. johnsonii, A. radioresistens, and as the unnamed phenons 6, 10, and 14, by a numerical approach using a simplified phenotypical identification scheme. Most of the remaining strains were identified to the genotypically heterogeneous A. calcoaceticus-A. baumannii complex and the A. lwoffii phenotype. Sixteen strains (14%) were left unidentified. Eight A. lwoffii strains were glucose-oxidizing and were thus classified as b. anitratus using the old terminology. The strains were tested for susceptibility to ampicillin, piperacillin, ticarcillin, cefotaxime, ceftazidime, imipenem, gentamicin, tetracycline, sulphonamide, and nalidixic acid. All strains were susceptible to imipenem. The susceptibility to the remaining beta-lactams was variable, the A. lwoffii isolates being the most and the A. calcoaceticus-A. baumannii complex strains the least susceptible. All non-A. calcoaceticus-A. baumannii complex strains were susceptible to all other antibiotics tested, except for one A. lwoffii strain that was sulphonamide resistant. Twenty-two percent of the strains in the A. calcoaceticus-A. baumannii complex showed reduced susceptibility or resistance to gentamicin, but only sporadic resistance to sulphonamides, tetracyclines, and nalidixic acid. Eight infections were recorded: three cases of septicaemia, three cases of peritonitis related to continuous ambulatory peritoneal dialysis, and two cases of recurrent urinary tract infection. No epidemics were detected.

Entities:  

Mesh:

Year:  1993        PMID: 8286090     DOI: 10.1111/j.1699-0463.1993.tb00186.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  11 in total

Review 1.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Surveillance of infections in hospital: agents and antibiotic-resistance.

Authors:  F Riccardi; A Noce; S Falco; P Giudiceandrea; L Palombi; A Panà
Journal:  Eur J Epidemiol       Date:  1997-02       Impact factor: 8.082

3.  Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates.

Authors:  Yu Mi Lim; Kyeong Seob Shin; Jungmin Kim
Journal:  J Clin Microbiol       Date:  2006-12-27       Impact factor: 5.948

4.  Description of Leeds Acinetobacter Medium, a new selective and differential medium for isolation of clinically important Acinetobacter spp., and comparison with Herellea agar and Holton's agar.

Authors:  A Jawad; P M Hawkey; J Heritage; A M Snelling
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

Review 5.  Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.

Authors:  J A Balfour; H M Bryson; R N Brogden
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

6.  Evaluation of the ability of a commercial system to identify Acinetobacter genomic species.

Authors:  A T Bernards; J van der Toorn; C P van Boven; L Dijkshoorn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

7.  Comparison of a repetitive extragenic palindromic sequence-based PCR method and clinical and microbiological methods for determining strain sources in cases of nosocomial Acinetobacter baumannii bacteremia.

Authors:  David Martín-Lozano; José Miguel Cisneros; Berta Becerril; Lucila Cuberos; Trinidad Prados; Carlos Ortíz-Leyba; Elías Cañas; Jerónimo Pachón
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

8.  Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis.

Authors:  M Vaneechoutte; L Dijkshoorn; I Tjernberg; A Elaichouni; P de Vos; G Claeys; G Verschraegen
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

9.  In vitro activity and in vivo efficacy of clavulanic acid against Acinetobacter baumannii.

Authors:  Alejandro Beceiro; Rafael López-Rojas; Juan Domínguez-Herrera; Fernando Docobo-Pérez; Germán Bou; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2009-07-27       Impact factor: 5.191

Review 10.  Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  C P Rains; H M Bryson; D H Peters
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.